Researchers at Barrow Neurological Institute in Phoenix have developed a new method that allows technicians to obtain clearer Magnetic Resonance Imaging (MRI) scans with less sensitivity to patient motion.
PROPELLER is an acronym for "Periodically Rotated Overlapping ParallEL Lines with Enhanced Reconstruction." This method acquires data in a unique way that allows one to track the motion of the patient during the MRI scan. The motion can then be removed.
"While PROPELLER technology continues to be refined, GE has already incorporated the novel method into new medical equipment," said Jim Pipe, senior staff scientist in the MRI Department at Barrow. "We believe that PROPELLER technology will help drive the future of MRI."
There are two major applications for this method. The first is motion-insensitive imaging. For the first time, high-quality MRI scans can be collected on many segments of the population who cannot hold still (children, Parkinson’s patients, etc.). This is leading the technology to a point where patient motion, which may be the biggest obstacle to good images, is no longer a factor.
The second application for PROPELLER is stroke imaging. The technology used to detect and characterize strokes, called "Diffusion Weighted Imaging (DWI)," is extremely sensitive to even minute motion in a patient. Prior to PROPELLER, DWI images suffered in quality because the methods used to reduce this motion sensitivity also reduced image quality. With PROPELLER DWI, small strokes are much easier to detect, grade and follow during treatment.
New insight into the brain’s hidden depths: Jena scientists develop minimally-invasive endoscope
27.11.2018 | Leibniz-Institut für Photonische Technologien e. V.
New China and US studies back use of pulse oximeters for assessing blood pressure
21.11.2018 | University of British Columbia
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences